Pharmaceuticals Ltd Cadila is 10% at NOVAVAX INC (NVAX). They have made 1 open-market trade across 1 company since 2014, most recently 2014-03-21.
CIK 0001461239
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NVAX | 10,500,000 | $118.1M |
Shares reported on the most recent Form 4, priced at the 2014-03-21 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NVAX | SELL | 2014-03-19 | 2014-03-21 | $4.95 | $14.8M | -26.3% | -3.5% | -3.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.